RNA binding proteins and the pathological cascade in ALS/FTD neurodegeneration

Daisuke Ito, Mami Hatano, Norihiro Suzuki

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Advanced genetic approaches have accelerated the identification of causative genes linked to the neurodegenerative diseases amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Most of the disease-related proteins encoded by these genes form aggregates in the cellular machineries that regulate RNA and protein quality control in cells. Cross-talk among the signaling pathways governing these machineries leads to pathological cascadesmediated by the accumulation of mutant RNA binding proteins.We outline themolecular basis of ALS and FTD pathogenesis and discuss the prospects for therapeutic strategies to treat these diseases.

Original languageEnglish
Article number5436
JournalScience Translational Medicine
Volume9
Issue number415
DOIs
Publication statusPublished - 2017 Nov 8

Fingerprint

RNA-Binding Proteins
Mutant Proteins
Neurodegenerative Diseases
Quality Control
Proteins
RNA
Genes
Frontotemporal Dementia With Motor Neuron Disease
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

RNA binding proteins and the pathological cascade in ALS/FTD neurodegeneration. / Ito, Daisuke; Hatano, Mami; Suzuki, Norihiro.

In: Science Translational Medicine, Vol. 9, No. 415, 5436, 08.11.2017.

Research output: Contribution to journalArticle

@article{f3fc56ed5ea74a6692d7df8932bfe8c5,
title = "RNA binding proteins and the pathological cascade in ALS/FTD neurodegeneration",
abstract = "Advanced genetic approaches have accelerated the identification of causative genes linked to the neurodegenerative diseases amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Most of the disease-related proteins encoded by these genes form aggregates in the cellular machineries that regulate RNA and protein quality control in cells. Cross-talk among the signaling pathways governing these machineries leads to pathological cascadesmediated by the accumulation of mutant RNA binding proteins.We outline themolecular basis of ALS and FTD pathogenesis and discuss the prospects for therapeutic strategies to treat these diseases.",
author = "Daisuke Ito and Mami Hatano and Norihiro Suzuki",
year = "2017",
month = "11",
day = "8",
doi = "10.1126/scitranslmed.aah5436",
language = "English",
volume = "9",
journal = "Science Translational Medicine",
issn = "1946-6234",
publisher = "American Association for the Advancement of Science",
number = "415",

}

TY - JOUR

T1 - RNA binding proteins and the pathological cascade in ALS/FTD neurodegeneration

AU - Ito, Daisuke

AU - Hatano, Mami

AU - Suzuki, Norihiro

PY - 2017/11/8

Y1 - 2017/11/8

N2 - Advanced genetic approaches have accelerated the identification of causative genes linked to the neurodegenerative diseases amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Most of the disease-related proteins encoded by these genes form aggregates in the cellular machineries that regulate RNA and protein quality control in cells. Cross-talk among the signaling pathways governing these machineries leads to pathological cascadesmediated by the accumulation of mutant RNA binding proteins.We outline themolecular basis of ALS and FTD pathogenesis and discuss the prospects for therapeutic strategies to treat these diseases.

AB - Advanced genetic approaches have accelerated the identification of causative genes linked to the neurodegenerative diseases amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Most of the disease-related proteins encoded by these genes form aggregates in the cellular machineries that regulate RNA and protein quality control in cells. Cross-talk among the signaling pathways governing these machineries leads to pathological cascadesmediated by the accumulation of mutant RNA binding proteins.We outline themolecular basis of ALS and FTD pathogenesis and discuss the prospects for therapeutic strategies to treat these diseases.

UR - http://www.scopus.com/inward/record.url?scp=85033663164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033663164&partnerID=8YFLogxK

U2 - 10.1126/scitranslmed.aah5436

DO - 10.1126/scitranslmed.aah5436

M3 - Article

VL - 9

JO - Science Translational Medicine

JF - Science Translational Medicine

SN - 1946-6234

IS - 415

M1 - 5436

ER -